ArticleDalton transactions (Cambridge, England : 2003)2017
cis-Tetrachlorido-bis(indazole)osmium(iv) and its osmium(iii) analogues: paving the way towards the cis-isomer of the ruthenium anticancer drugs KP1019 and/or NKP1339.
Article in Dalton transactions (Cambridge, England : 2003), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 17 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors at 6 institutions in 5 countries.
Gabriel E BüchelDivision of Physical Sciences and Engineering, KAUST Catalysis Center, King Abdullah University of Science and Technology, Thuwal 23955-6900, Saudi Arabia and Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA.ORCID http://orcid.org/0000-0002-5055-7099
Susanne KossatzDepartment of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA.
Ahmad SadiqueDepartment of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA.
Peter RaptaSlovak University of Technology, Institute of Physical Chemistry and Chemical Physics, Radlinského 9, 81237 Bratislava, Slovakia. peter.rapta@stuba.sk.
Michal ZaliberaSlovak University of Technology, Institute of Physical Chemistry and Chemical Physics, Radlinského 9, 81237 Bratislava, Slovakia. peter.rapta@stuba.sk.ORCID http://orcid.org/0000-0002-6527-1982
Lukas BucinskySlovak University of Technology, Institute of Physical Chemistry and Chemical Physics, Radlinského 9, 81237 Bratislava, Slovakia. peter.rapta@stuba.sk.
Stanislav KomorovskyInstitute of Inorganic Chemistry, Slovak Academy of Sciences, Dúbravská cesta 9, SK-84536 Bratislava, Slovakia.ORCID http://orcid.org/0000-0002-5317-7200
Joshua TelserDepartment of Biological, Chemical and Physical Sciences, Roosevelt University, 430 S. Michigan Avenue, Chicago, Illinois 60605, USA. jtelser@roosevelt.edu.ORCID http://orcid.org/0000-0003-3307-2556
Jörg EppingerDivision of Physical Sciences and Engineering, KAUST Catalysis Center, King Abdullah University of Science and Technology, Thuwal 23955-6900, Saudi Arabia.ORCID http://orcid.org/0000-0001-7886-7059
Thomas ReinerDepartment of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA and Department of Radiology, Weill Cornell Medical College, New York, NY 10065, USA.
Vladimir B ArionUniversity of Vienna, Faculty of Chemistry, Institute of Inorganic Chemistry, Währinger Str. 42, A-1090 Vienna, Austria. vladimir.arion@univie.ac.at.ORCID http://orcid.org/0000-0002-1895-6460
Memorial Sloan Kettering Cancer Center · USSlovak University of Technology in Bratislava · SKKing Abdullah University of Science and Technology · SARoosevelt University · USSlovak Academy of Sciences · SKUniversity of Vienna · AT
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Coboglobins-Cobalt-Substituted Hemoglobins and MyoglobinR01GM111097 · NIGMS · NORTHWESTERN UNIVERSITY · PI HOFFMAN, BRIAN M · 2014 to 2025
$6.7M
Radioiodinated Multifunctional PARP1 Imaging Probes for Diagnosis and TherapyR01CA204441 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI PILLARSETTY, NAGAVARAKISHORE · 2016 to 2020
$2.9M
Development of Nuclear Auger Emitters for Targeted RadiotherapyR21CA191679 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI REINER, THOMAS, WEBER, WOLFGANG · 2015 to 2016
The relationship between cis-trans isomerism and anticancer activity has been mainly addressed for square-planar metal complexes, in particular, for platinum(ii), e.g., cis- and trans-[PtCl
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
cis-Tetrachlorido-bis(indazole)osmium(iv) and its osmium(iii) analogues: paving the way towards the cis-isomer of the ruthenium anticancer drugs KP1019 and/or NKP1339. · full record | OpenQuestion